Item 2. Properties

2K characters. Original on sec.gov · Markdown

Item 2. Properties

We conduct our research, development, manufacturing, and administrative activities at our owned and leased facilities. A summary of our significant owned and leased properties is provided below.


Location	Approximate Square Feet	Use	Leased/Owned
Tarrytown, New York	1,500,000	Corporate headquarters, laboratory, and office space	Leased(a)
Rensselaer, New York	1,600,000	Manufacturing, warehouse, laboratory, fill/finish(b), and office space	Owned
Limerick, Ireland	850,000	Manufacturing, warehouse, laboratory, and office space	Owned
(a) Refer to Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Tarrytown, New York Corporate Headquarters Lease" for further details.
(b) Our fill/finish facility in Rensselaer, New York is currently undergoing process validation as required by regulatory authorities.

In addition to the properties summarized in the table above, we own an approximate 100-acre parcel of land adjacent to our Tarrytown, New York location, which we are in the process of developing, primarily to expand our research, preclinical manufacturing, and support facilities to accommodate our growth. In September 2024, we also acquired an approximate 1,000,000 square foot facility in Saratoga Springs, New York.

Previous: Item 1C. Cybersecurity · Next: Item 3. Legal Proceedings